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Abstract
Background: Independently of the fetal death cause the beginning and course of stillbirth is closely
related with the growing cytotoxic activity at the maternal-fetal interface. RCAS1 participates in
the inhibition of maternal immune response during pregnancy. The alterations of RCAS1 protein
expression in placental cells seem to determine the beginning of the labor and participate in the
placental abruption. The aim of the present study was to investigate RCAS1 expression in placentas
obtained following stillbirths or normal term births. Methods: RCAS1 expression was evaluated by
Western blot method with the use of monoclonal anti-RCAS1 antibody in 67 placental tissue
samples. Pregnant women were divided into four groups according to the mode of labor onset –
spontaneous or induced, and the type of labor, stillbirth or labor at term. Placental beta-Actin
expression was chosen as a control protein. Relative amounts of placental RCAS1 were compared
with the use of Student's t-test, whereas beta-Actin control data were compared with the use of
Mann-Whitney U test. Results: The average relative amount of RCAS1 was significantly lower in
women with induced stillbirths than in women with induced labor at term. Similarly, significantly
lower RCAS1 placental levels were observed in patients with spontaneous stillbirths than in women
with spontaneous labor at term. Significant differences in RCAS1 expression were also observed
with the respect to the beginning of the stillbirth: spontaneous and induced. Lowest RCAS1
placental levels were observed in women with spontaneous stillbirth. Conclusions: These
preliminary results indicate that the alterations of RCAS1 expression in the human placenta may
be involved in the changes of maternal immune system that take place during stillbirth.
Background
Dynamic fetal growth observed between 20th and 28th
week of pregnancy is accompanied by fetal maturation
which enables further uncomplicated extra-uterine
growth. The fetal development is possible due to the phe-
nomenon of maternal immunological tolerance to fetal
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antigens. Severe disturbances of the fetal growth might in
some cases result in fetal intrauterine death. Some of the
most common fetal death causes constituting about 50%
of all cases include placental maturation disorders and
fetal congenital malformations [1]. Stillbirth may be con-
sidered a form of complicated vaginal labor. Independ-
ently of the fetal death cause the beginning and course of
stillbirth is closely related to the growing cytotoxic activity
at the maternal-fetal interface. However, this activity does
not have to arise simultaneously with the fetal death. In
some situations fetal death may not be accompanied by
immediate clinical features of the onset of labor. Molecu-
lar changes in membrane proteins expressed by trophob-
last cells usually lead to the beginning of normal term
delivery but may also be found in stillbirth. These proteins
are neccessary for the development of maternal immune
tolerance phenomenon. Cellular membrane proteins
expressed by trophoblast cells that seem to be responsible
for suppressing CTLs, dNK and NK cells are: Fas/Fas-L,
killer inhibitory receptors family (KIRs), tumor necrosis
factor receptors family (TNF) and others [2-4]. Recently, a
novel factor called RCAS1 has been described [4-6].
RCAS1 is a type II membrane protein, expressed in extra-
villous cytotrophoblast, villi-histiocytes, uterine
endometrium and in various human cancer cells [7-12].
This protein acts as a ligand for a putative receptor that
may be present on normal peripheral lymphocytes such as
T, B, and NK cells. RCAS1 inhibits the growth of receptor
expressing cells in vitro and in vivo and induces apoptotic
cell death [13]. Main functions of RCAS1 include avoiding
of immune recognition and evading immune surveillance
by inhibition of maternal immune attack against fetal
antigens [4,5]. The alterations of RCAS1 protein expres-
sion in placental cells seem to determine the onset of
labor and participate in the placental abruption [5,6]. The
aim of our study was to evaluate the changes of RCAS1
placental level during the stillbirths.
Methods
2.1. The subjects
Relative amount of RCAS1 content was estimated in 67
placental tissue samples taken from normal term deliver-
ies and from stillborn fetuses. Informed consent for the
use of placental tissue was obtained from all patients. The
approval from the Ethical Committee of the Jagiellonian
University in Krakow (KBET/379/13/2003) for this
research program was also granted. Stillborns were
defined as dead-born fetuses either upon completion of
23 weeks of gestation, or when the fetal weight was over
400 grams. Autopsy was performed in Pathomorphology
Department of Jagiellonian University in all cases. Based
on the autopsy report review we included cases of intrau-
terine fetal death caused by fetal congenital malforma-
tions. According to the onset of stillbirth patients were
devided into four groups. The first group included 6
women in whom labor was induced following the recog-
nition of the intrauterine fetal death. The second group
consisted of 5 women with stillbirths with spontaneous
onset of labor. Two control groups consisted of pregnant
women with normal term birth (37–43 completed week'
gestation), and were selected according to the onset of
labor, that was spontaneous (group III) or induced (group
IV). The former group consisted of 31 pregnant women
with spontaneous onset of vaginal deliveries preceded by
the regular uterine contractions during first and second
stage of the labor. The latter group included 25 women
with induced vaginal term deliveries. Maternal character-
istics of the women are shown in Table 1. Patients with
preterm deliveries, chorioamnionitis, hypertension, dia-
betes mellitus and multiple pregnancies were excluded.
All placentas were histologically examined by an experi-
enced pathologist.
2.2 Preparation of tissue extracts
Tissue samples (app. 0.5 × 0.5 × 0.5 cm) were obtained
from the central part of the placenta collected following
delivery and stillbirth and were immediately frozen. The
0.5 cm thick tissue samples contained villous lamina
(extra-villous cytotrophoblast cells and syncytiotrophob-
last) and cells from maternal decidua compacta (the exter-
nal part of decidua basalis). The specimens were mixed
with complete proteinase inhibitor cocktail (Roche, Ger-
many) and homogenized on ice-bath in glass-glass Potter-
Elvejhem homogenizer. The resulting suspensions were
mixed with equal volume of SDS sample lysis buffer (4%
SDS, 20% glycerol, 125 mM Tris-HCl pH 6.8) and boiled
on water bath by 5 minutes. The chilled samples were
then centrifuged at 16,000 g for 15 min at room tempera-
ture. The collected supernatants were used for further
analysis.
Table 1: The characteristics of subjects
Pregnant women 
(n = 67)
Maternal age ± SD 
(y)
Gestational age ± SD 
(wk)
Nulliparous 
(%)
Birth weight ± SD 
(g)
Mean Apgar ± SD
Induced stillbirths (n = 6) 28.5 (± 5.24) 25.23 (± 1.36) 33.3 612.6 (± 172.2) -
Spontaneous stillbirths (n = 5) 27 (± 5.91) 25.57 (± 1.43) 40 650 (± 145.4) -
Induced labor at term (n = 25) 28.07 (± 4.55) 38.96 (± 1.83) 60 3290 (± 467) 9.34 (± 2.02)
Spontaneous labor at term (n = 31) 28.16 (± 6.04) 39.68 (± 2.36) 58 3138 (± 649) 9.5 (± 1.22)
SD – standard deviation; (n – number of tissue samples)Reproductive Biology and Endocrinology 2005, 3:24 http://www.rbej.com/content/3/1/24
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2.3. Western blotting
Total protein content in the obtained supernatants was
measured using BCA assay kit and different sample vol-
umes (usually in the range of 2–10 µl) equivalent to 50 µg
of total protein were then loaded on SDS-PAGE tris-tricine
peptide-separating gels. Prestained broad range molecular
weight proteins standard (Bio Rad, USA) was used in gel
marker lane. Following electrophoresis the gels were elec-
trotransferred on Immobilon-P polyvinylidene difluoride
(PVDF) 0.45 µm membrane (Millipore, USA) in the
buffer containing 10 mM 3-[cyclohexyloamino]-1-pro-
panesulfonic acid (CAPS) pH 11, supplemented with
10% methanol. The obtained membrane blots were
blocked overnight by gentle agitation in 5% bovine albu-
min in TST buffer (0.01 M Tris-HCl, pH 7.4, 0.9%NaCl),
0.5% Tween-20). All described procedures were per-
formed at room temperature. Albumin solution was dis-
carded and the membranes were then agitated for 2 hrs in
TST with the mouse monoclonal anti-RCAS1 IgM-class
antibody, 1: 4 000 dilution (Medical and Biological Labo-
ratories, Japan). The membranes were then subjected to 4
cycles of washings in TST, 5 minutes each and immersed
for agitation in the 1 : 2 000 dilution of SIGMA bioti-
nylated anti-mouse IgM µ-chain specific antibodies for a
2 hours period. After 4 cycles of washings the membranes
were then treated for 2 hours in 1 : 2 000 dilution of ExtrA-
vidin alkaline phosphatase conjugate (SIGMA, USA) and
finally washed 2 times in TST and 2 times in TST without
Tween-20. Color reaction was developed with the use of
Fast Red TR/Naphtol AS-MX tablet set (SIGMA, USA). A
sufficient bands intensity was obtained usually following
5 min period of developing. Obtained immunoblotts
were then rinsed with distilled water and air-dried.
Detailed description of the tissue preparation and semi-
quantitative assessment of RCAS1 and control beta-Actin
relative amounts in the tissue samples using Western blot
technique has been presented in our previous reports
[5,6]. The RCAS1 antigen was identified as a 32 kDa band
and β -actin represented a 42 kDa band [6,10,11].
2.4. Computer-aided image analysis
Fluor-S MultiImager (BioRad, USA) was used to scan
immunoblotted membranes and a QuantityOne software
(BioRad, USA) was used to quantitate band intensities. All
calculations were performed on RCAS1 antigen band hav-
ing molecular mass of about 32 kDa [6,10,11]. The inten-
sities of this band were expressed in arbitrary relative units
and one unit (U) was defined as band intensity produced
in the reference sample. This reference sample was ran-
domly chosen but was strictly the same on all blots and
was applied always in the same amount. Typical proce-
dure of RCAS1 quantitation was as follows: scanned
immunoblot membrane contained one lane of molecular
mass standards, while one lane of sample used as a refer-
ence to calibrate RCAS1 amount and 12 lanes containing
unknown samples. The location of 32 kDa RCAS1 bands
in reference and unknown lanes was identified according
to the lane containing molecular mass standard. The 32
kDa RCAS1 band intensities in reference and in unknown
lanes were then calculated and expressed in pixel number
units. These units were divided by pixel number of refer-
ence lane band which resulted in relative intensity units
"U". The resulting intensity of reference lane band was
always 1.00 U while the intensities of bands from 12
unknown sample lanes on the same membrane changed
according to RCAS1 level (e.g., if RCAS1 amount in a
given sample was 2 times higher than this in reference
sample the result was 2.00 U. If the RCAS1 amount was 2
times lower then the result was 0.50 U). As mentioned
earlier, because all immunoblots contained the same
RCAS1 quantity standard and all lanes were loaded with
the same amount of total protein (50 µg), the determined
values were highly repetitive and independent of experi-
ment conditions. The RCAS1 total amount in examined
tissue samples was recognized relatively, which was neces-
sary because no RCAS1 standard is available. The result
always shows relative amount of RCAS1 32 kD antigen in
50 µg of total sample protein [5,6].
2.4. Statistical analysis
The distribution of the subjects was analyzed with the use
of Shapiro-Wilk's test. RCAS1 were compared with the use
of Student's t-test whereas β -Actin control data were com-
pared with the use of Mann-Whitney U test. Differences
between studied groups were considered significant at p <
0.05.
Table 2: The comparison of RCAS1 average relative placental amount assessed by Western blot method during vaginal delivery 
according to the course of the labor.
RCAS1 placental relative amount (mean ± SD) β -Actin placental relative amount (mean ± SD)
Spontaneous stillbirths (n = 5) 0.2102 (± 0.0601) 1.1383 (± 0.1438)
Induced stillbirths (n = 6) 0.3334 (± 0.1387) 1.0924 (± 0.1316)
Induced labor at term (n = 25) 0.7131 (± 0.2896) 1.1559 (± 0.7445)
Spontaneous labor at term (n = 31) 0.4775 (± 0.2728) 1.1206 (± 0.5316)
SD-standard deviation; (n – number of tissue samples)Reproductive Biology and Endocrinology 2005, 3:24 http://www.rbej.com/content/3/1/24
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Results
The presence of RCAS1 expression was evaluated in all
placental tissue samples derived from vaginal deliveries at
term and stillbirths. The relative amount of β -Actin in all
groups were found to be identical (table 2), this indicate
that equal loading of proteins was performed and allow a
comparative study between RCAS1 expression in each
group.
The average relative amount of RCAS1 was significantly
lower in placental tissue samples obtained from induced
stillbirths than from samples collected following induced
labor at term (p = 0.004). Also, average RCAS1 expression
observed in placental tissue samples from women with
spontaneous stillbirths was significantly lower than pla-
cental protein expression in samples from women with
term labor with spontaneous beginning (p = 0.03). Signif-
icantly higher RCAS1 placental levels were found in
women with induced labor when compared to women
with spontaneous onset of labor at term (p < 0.001). Sig-
nificant differences in RCAS1 expression were also
observed within the group of stillbirths with the respect to
the beginning of the stillbirth: spontaneous and induced
(p = 0.06).
Discussion
In order to investigate the possible role of RCAS1 in initi-
ation of stillbirth, the expression levels of this protein
were determined and compared between groups of
patients with spontaneous and induced onset of stillbirth.
The RCAS1 expression observed during spontaneous still-
birth was lower than the level of this protein found in
induced stillbirth. Immune activity alterations noted dur-
ing gestation have a local range and concern the
endometrium-associated lymphoid tissue. Trophoblast
cells participate in this phenomenon. Syncytiotrophob-
last is terminally differentiated to functional trophoblast.
The ratio of syncytiotrophoblast to cytotrophoblast
increases with advancing gestation and at term syncytio-
trophoblast occupies almost the entire placenta. The dif-
ferentiation from cytotrophoblast to syncytiotrophoblast
is identical to placenta development [14]. The cells of syn-
cytiotrophoblast and cytotrophoblast play an important
role in the function of the feto-maternal unit. The decrease
of immune tolerance at term leads to the beginning of
spontaneous labor, earlier appearance of this phenome-
non may lead to miscarriage or preterm labor [15].
The activation of endometrium-associated lymphoid tis-
sue is provided mainly by lymphocyte-mediated cytotox-
icity. Normal endometrium is infiltrated predominantly
by T lymphocytes, NK cells and macrophages. Increased
number of B lymphocytes which constitute a small per-
centage during physiological cycle changes in
endometrium is observed only in endometritis [16]. The
analysis of mononuclear cells distribution in deciduas of
term placentae revealed significantly increased number of
dNK, NK and macrophages [17].
Our previous studies confirmed the observation of
decreased RCAS1 expression level during labor of sponta-
neous onset when compared to induced labor at term. The
decreased RCAS1 expression level seems to confirm the
observation of higher dNK, NK activity, which might be
clinically observed in the beginning of spontaneous labor,
preterm labor or stillbirths [5]. Clinically asymptomatic
onset of stillbirth indicates that that fetal demise might
not be immediately recognized by maternal immune sys-
tem. Lower placental RCAS1 expression in women with
spontaneous beginning of stillbirth in comparison to
induced stillbirths observed in our study seems to confirm
this hypothesis. A correlation between RCAS1 expression
and the infiltration by dNK cells in the human uterus
found in early stage of pregnancy was observed by
Oshima et al. [4]. In this study, in cases without maternal
rejection RCAS1 was expressed mainly in trophoblast. In
contrast, in cases with maternal rejection the expression of
RCAS1 decreased strikingly. These changes were also
accompanied by marked infiltration and activation of
dNK cells. Normal placentas at term were selected as the
controls. Immunohistochemical localization revealed the
presence of RCAS1 in normal placental tissues at term.
Positive staining for RCAS1 was found predominantly in
extravillous cytotrophoblast and syncytiotrofoblast [4].
Therefore, it is possible that the onset of stillbirth may
also require the decrease of immune tolerance which may
reflect an increasing cytotoxic activity.
Conclusion
Our results indicate that alterations in RCAS1 expression
may be involved in the changes of maternal immune sys-
tem that take place during stillbirth.
List of abbreviations
RCAS1 (receptor-binding cancer antigen expressed on
SiSo cells); CTLs (cytotoxic T lymphocytes); dNK (decid-
ual natural killer); KIRs (killer inhibitory receptors); TNF
(tumor necrosis factor).
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